HPV Testing and Pap Test Market by Test Types (HPV Testing and Pap Test), Applications (Cervical Cancer Screening and Vaginal Cancer Screening), Products (Instruments, Consumables, and Services), Technology (PCR, Immunodiagnostics, and Others), End-users (Hospitals & Clinics, Laboratories, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
The HPV testing and Pap test market size was valued at USD 1.67 billion in 2020 and is expected to surpass USD 7.25 billion, expanding at a CAGR of 16.4% during the forecast period, 2021–2028. The growth of the market is attributed to the rising number of cervical cancer screening events and development of several innovative screening devices.
HPV testing and Pap test are primarily used for the detection of cancerous cells in the body. HPV or human papillomavirus consists of a group of more than 150 related viruses and Pap tests are widely used to identify tumor formation and precancers in the cervix. Precancers are mainly caused by HPV and some of the HPV types develops cervical cancer without proper treatment. Some of the most common consequences of the HPV include cancer formation in several body parts such as vagina, vulva, anus, and penis along with some parts of the mouth and throat, and cervix. A Pap test is done for precancerous conditions of vaginal cancer, cervix, and cervical cancer. In the COVID-19 situation impacted by emergency lockdown, the number of cervical cancer screening test globally had decreased to 80% as compared to the previous decline record of 94% in April 25, 2020.
According to the World Health Organization (WHO), approximately 99% cases of cervical cancer are linked with HPV infection. The cervical cancer is common among women above the age of 40 years and is largely diagnosed among women between the ages of 35 to 44 years. The increasing number of awareness events and programs by healthcare organizations such as WHO, CDC, the U.S. Preventive Services Task Force, and National Cervical Cancer Coalition is one of the key aspects for the market growth. In the UK, the Public Health England initiated awareness campaign to increase adoption of the screening tests among women in the country, which plays a crucial role for the rising use of testing procedures in the country.
Market Trends, Drivers, Restraints, and Opportunities
- Rising number of cervical cancer cases worldwide present key factor driving the market growth.
- Increasing governments’ initiatives and policies for public awareness programs especially for women are another major factors for the market expansion.
- High incidence of cervical cancer especially vaginal cancer and increasing demand for innovative screening techniques for the treatment are major factors which are expected to drive the market growth.
- Increasing technology advancement in diagnostic procedures and development of several screening techniques by major players in the market are likely to boost the market.
- The COVID-19 pandemic and its dire consequences have impacted to enormously reduce regular cancer screening tests. This acts as a key restraining factor for the market.
Scope of the Report
The report on the global HPV testing and Pap test market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
| Attributes | Details |
| Report Title | HPV Testing and Pap Test Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
| Base Year | 2020 |
| Historic Data | 2018–2019 |
| Forecast Period | 2021–2028 |
| Segmentation | Test Types (HPV Testing and Pap Test), Applications (Cervical Cancer Screening and Vaginal Cancer Screening), Products (Instruments, Consumables, and Services), Technology (PCR, Immunodiagnostics, and Others), End-users (Hospitals & Clinics, Laboratories, and Others) |
| Regional Scope | Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
| Report Coverage | Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
| Key Players Covered in the Report | Abbott Laboratories; Qiagen N.V.; Becton, Dickinson and Company; Quest Diagnostics, Inc.; Hologic, Inc.; F. Hoffmann-La Roche AG; Femasys, Inc.; Arbor Vita Corporation; NURX, Inc.; Seegene, Inc.; Thermo Fisher Scientific, Inc.; and bioMérieux SA |
Market Segment Insights
HPV testing segment is expected to grow at a rapid pace
Based on test types, the global HPV testing and Pap test market is bifurcated into HPV testing and Pap test. The HPV testing segment is expected to grow at a rapid pace during the projected period due to rising commercialization of innovative tests related to HPV infection. However, the Pap test segment is anticipated to account for a key share of the market during the forecast period owing to increasing awareness programs by healthcare authorities and rising implementation of policies to adopt mandatory screening of cervical cancer.
Vaginal cancer screening segment is projected to expand at a considerable CAGR
On the basis of applications, the market is bifurcated into cervical cancer screening and vaginal cancer screening. The cervical cancer screening segment is projected to hold a key market share in the coming years owing to higher incidence of cervical cancer and growing public-private initiatives to increase screening of cervical cancer. On the other hand, the vaginal cancer screening segment is anticipated to expand at a considerable CAGR during the forecast period due to high mortality rates of vaginal cancer and demand for screening test.
Consumables segment is expected to expand at a robust growth rate
Based on products, the global HPV testing and Pap test market is divided into instruments, consumables, and services. The services segment is anticipated to constitute a large market share during the projected period due to the increase in number of at-home screening of cervical cancer. On the other hand, the consumables segment is anticipated to expand at a robust growth rate during the forecast period owing to growing activities by key market players through the launch of novel consumables such as assays and kits for more precise HPV and Pap tests.
PCR segment is expected to register a high CAGR
On the basis of technology, the market is divided into PCR, immunodiagnostics, and others. The PCR segment is expected to register a high CAGR during the projected period due to the execution of new rules for utilizing DNA HPV testing methods for accurate and inexpensive treatment. On the other hand, the others segment is projected to account for a major share of the market during the forecast period owing to adoption of cystoscopy and colposcopy techniques cervical cancer screenings and in HPV.
Hospitals & clinics segment is expected to grow at a considerable rate
Based on end-users, the global HPV testing and Pap test market is classified into hospitals & clinics, laboratories, and others. The hospitals & clinics segment is expected to grow at a considerable rate as these institutions provide primary care services for the treatment of all diseases including cervical cancer and HIV. Meanwhile, the others segment is anticipated to expand at a rapid pace during the forecast period due to rise in the number of usage of POC test in-home settings.
North America is anticipated to constitute a key market share
In terms of regions, the global HPV testing and Pap test market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to constitute a key share of the market during the targeted period owing to increased awareness about early diagnosis of cervical cancer and healthcare remuneration scenarios in the region. On the other hand, the market of Asia Pacific is anticipated to expand at a healthy growth rate during the forecast period due to rising number of cancers and increasing adoption of advanced technology in the region.
Segments
Segments Covered in the Report
The global HPV testing and Pap test market has been segmented on the basis of
Test Types
- HPV Testing
- Pap Test
Applications
- Cervical Cancer Screening
- Vaginal Cancer Screening
Products
- Instruments
- Consumables
- Services
Technology
- PCR
- Immunodiagnostics
- Others
End-users
- Hospitals & Clinics
- Laboratories
- Others
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Abbott Laboratories
- Qiagen N.V.
- Becton, Dickinson and Company
- Quest Diagnostics, Inc.
- Hologic, Inc.
- F. Hoffmann-La Roche AG
- Femasys, Inc.
- Arbor Vita Corporation
- NURX, Inc.
- Seegene, Inc.
- Thermo Fisher Scientific, Inc.
- BioMérieux SA
Competitive Landscape
Key players competing in the HPV testing and Pap test market are Abbott Laboratories; Qiagen N.V.; Becton, Dickinson and Company; Quest Diagnostics, Inc.; Hologic, Inc.; F. Hoffmann-La Roche AG; Femasys, Inc.; Arbor Vita Corporation; NURX, Inc.; Seegene, Inc.; Thermo Fisher Scientific, Inc.; and bioMérieux SA. Qiagen N.V. developed the QIAscreen HPV PCR Test, in November 2018, which was a molecular diagnostic test used to diagnose HPV.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. HPV Testing and Pap Test Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. HPV Testing and Pap Test Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. HPV Testing and Pap Test Market - Supply Chain
4.5. Global HPV Testing and Pap Test Market Forecast
4.5.1. HPV Testing and Pap Test Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. HPV Testing and Pap Test Market Size (000’ Units) and Y-o-Y Growth
4.5.3. HPV Testing and Pap Test Market Absolute $ Opportunity
5. Global HPV Testing and Pap Test Market Analysis and Forecast by Applications
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Applications
5.2.2. Y-o-Y Growth Projections by Applications
5.3. HPV Testing and Pap Test Market Size and Volume Forecast by Applications
5.3.1. Cervical Cancer Screening
5.3.2. Vaginal Cancer Screening
5.4. Absolute $ Opportunity Assessment by Applications
5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global HPV Testing and Pap Test Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. HPV Testing and Pap Test Market Size and Volume Forecast by End Users
6.3.1. Hospitals & Clinics
6.3.2. Laboratories
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global HPV Testing and Pap Test Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. HPV Testing and Pap Test Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global HPV Testing and Pap Test Demand Share Forecast, 2019-2026
8. North America HPV Testing and Pap Test Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America HPV Testing and Pap Test Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America HPV Testing and Pap Test Market Size and Volume Forecast by Applications
8.4.1. Cervical Cancer Screening
8.4.2. Vaginal Cancer Screening
8.5. Basis Point Share (BPS) Analysis by Applications
8.6. Y-o-Y Growth Projections by Applications
8.7. North America HPV Testing and Pap Test Market Size and Volume Forecast by End Users
8.7.1. Hospitals & Clinics
8.7.2. Laboratories
8.7.3. Others
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America HPV Testing and Pap Test Demand Share Forecast, 2019-2026
9. Latin America HPV Testing and Pap Test Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America HPV Testing and Pap Test Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America HPV Testing and Pap Test Market Size and Volume Forecast by Applications
9.4.1. Cervical Cancer Screening
9.4.2. Vaginal Cancer Screening
9.5. Basis Point Share (BPS) Analysis by Applications
9.6. Y-o-Y Growth Projections by Applications
9.7. Latin America HPV Testing and Pap Test Market Size and Volume Forecast by End Users
9.7.1. Hospitals & Clinics
9.7.2. Laboratories
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America HPV Testing and Pap Test Demand Share Forecast, 2019-2026
10. Europe HPV Testing and Pap Test Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe HPV Testing and Pap Test Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe HPV Testing and Pap Test Market Size and Volume Forecast by Applications
10.4.1. Cervical Cancer Screening
10.4.2. Vaginal Cancer Screening
10.5. Basis Point Share (BPS) Analysis by Applications
10.6. Y-o-Y Growth Projections by Applications
10.7. Europe HPV Testing and Pap Test Market Size and Volume Forecast by End Users
10.7.1. Hospitals & Clinics
10.7.2. Laboratories
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe HPV Testing and Pap Test Demand Share Forecast, 2019-2026
11. Asia Pacific HPV Testing and Pap Test Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific HPV Testing and Pap Test Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific HPV Testing and Pap Test Market Size and Volume Forecast by Applications
11.4.1. Cervical Cancer Screening
11.4.2. Vaginal Cancer Screening
11.5. Basis Point Share (BPS) Analysis by Applications
11.6. Y-o-Y Growth Projections by Applications
11.7. Asia Pacific HPV Testing and Pap Test Market Size and Volume Forecast by End Users
11.7.1. Hospitals & Clinics
11.7.2. Laboratories
11.7.3. Others
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific HPV Testing and Pap Test Demand Share Forecast, 2019-2026
12. Middle East & Africa HPV Testing and Pap Test Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa HPV Testing and Pap Test Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa HPV Testing and Pap Test Market Size and Volume Forecast by Applications
12.4.1. Cervical Cancer Screening
12.4.2. Vaginal Cancer Screening
12.5. Basis Point Share (BPS) Analysis by Applications
12.6. Y-o-Y Growth Projections by Applications
12.7. Middle East & Africa HPV Testing and Pap Test Market Size and Volume Forecast by End Users
12.7.1. Hospitals & Clinics
12.7.2. Laboratories
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa HPV Testing and Pap Test Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global HPV Testing and Pap Test Market: Market Share Analysis
13.2. HPV Testing and Pap Test Distributors and Customers
13.3. HPV Testing and Pap Test Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Abbott Laboratories
13.4.2. Qiagen N.V.
13.4.3. Becton, Dickinson and Company
13.4.4. Quest Diagnostics, Inc.
13.4.5. Hologic, Inc.
13.4.6. F. Hoffmann-La Roche AG
13.4.7. Femasys, Inc.
2. Assumptions and Acronyms Used
3. Research Methodology
4. HPV Testing and Pap Test Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. HPV Testing and Pap Test Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. HPV Testing and Pap Test Market - Supply Chain
4.5. Global HPV Testing and Pap Test Market Forecast
4.5.1. HPV Testing and Pap Test Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. HPV Testing and Pap Test Market Size (000’ Units) and Y-o-Y Growth
4.5.3. HPV Testing and Pap Test Market Absolute $ Opportunity
5. Global HPV Testing and Pap Test Market Analysis and Forecast by Applications
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Applications
5.2.2. Y-o-Y Growth Projections by Applications
5.3. HPV Testing and Pap Test Market Size and Volume Forecast by Applications
5.3.1. Cervical Cancer Screening
5.3.2. Vaginal Cancer Screening
5.4. Absolute $ Opportunity Assessment by Applications
5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global HPV Testing and Pap Test Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. HPV Testing and Pap Test Market Size and Volume Forecast by End Users
6.3.1. Hospitals & Clinics
6.3.2. Laboratories
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global HPV Testing and Pap Test Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. HPV Testing and Pap Test Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global HPV Testing and Pap Test Demand Share Forecast, 2019-2026
8. North America HPV Testing and Pap Test Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America HPV Testing and Pap Test Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America HPV Testing and Pap Test Market Size and Volume Forecast by Applications
8.4.1. Cervical Cancer Screening
8.4.2. Vaginal Cancer Screening
8.5. Basis Point Share (BPS) Analysis by Applications
8.6. Y-o-Y Growth Projections by Applications
8.7. North America HPV Testing and Pap Test Market Size and Volume Forecast by End Users
8.7.1. Hospitals & Clinics
8.7.2. Laboratories
8.7.3. Others
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America HPV Testing and Pap Test Demand Share Forecast, 2019-2026
9. Latin America HPV Testing and Pap Test Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America HPV Testing and Pap Test Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America HPV Testing and Pap Test Market Size and Volume Forecast by Applications
9.4.1. Cervical Cancer Screening
9.4.2. Vaginal Cancer Screening
9.5. Basis Point Share (BPS) Analysis by Applications
9.6. Y-o-Y Growth Projections by Applications
9.7. Latin America HPV Testing and Pap Test Market Size and Volume Forecast by End Users
9.7.1. Hospitals & Clinics
9.7.2. Laboratories
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America HPV Testing and Pap Test Demand Share Forecast, 2019-2026
10. Europe HPV Testing and Pap Test Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe HPV Testing and Pap Test Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe HPV Testing and Pap Test Market Size and Volume Forecast by Applications
10.4.1. Cervical Cancer Screening
10.4.2. Vaginal Cancer Screening
10.5. Basis Point Share (BPS) Analysis by Applications
10.6. Y-o-Y Growth Projections by Applications
10.7. Europe HPV Testing and Pap Test Market Size and Volume Forecast by End Users
10.7.1. Hospitals & Clinics
10.7.2. Laboratories
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe HPV Testing and Pap Test Demand Share Forecast, 2019-2026
11. Asia Pacific HPV Testing and Pap Test Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific HPV Testing and Pap Test Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific HPV Testing and Pap Test Market Size and Volume Forecast by Applications
11.4.1. Cervical Cancer Screening
11.4.2. Vaginal Cancer Screening
11.5. Basis Point Share (BPS) Analysis by Applications
11.6. Y-o-Y Growth Projections by Applications
11.7. Asia Pacific HPV Testing and Pap Test Market Size and Volume Forecast by End Users
11.7.1. Hospitals & Clinics
11.7.2. Laboratories
11.7.3. Others
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific HPV Testing and Pap Test Demand Share Forecast, 2019-2026
12. Middle East & Africa HPV Testing and Pap Test Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa HPV Testing and Pap Test Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa HPV Testing and Pap Test Market Size and Volume Forecast by Applications
12.4.1. Cervical Cancer Screening
12.4.2. Vaginal Cancer Screening
12.5. Basis Point Share (BPS) Analysis by Applications
12.6. Y-o-Y Growth Projections by Applications
12.7. Middle East & Africa HPV Testing and Pap Test Market Size and Volume Forecast by End Users
12.7.1. Hospitals & Clinics
12.7.2. Laboratories
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa HPV Testing and Pap Test Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global HPV Testing and Pap Test Market: Market Share Analysis
13.2. HPV Testing and Pap Test Distributors and Customers
13.3. HPV Testing and Pap Test Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Abbott Laboratories
13.4.2. Qiagen N.V.
13.4.3. Becton, Dickinson and Company
13.4.4. Quest Diagnostics, Inc.
13.4.5. Hologic, Inc.
13.4.6. F. Hoffmann-La Roche AG
13.4.7. Femasys, Inc.
Segments Covered in the Report
The global HPV testing and Pap test market has been segmented on the basis of
Test Types
- HPV Testing
- Pap Test
Applications
- Cervical Cancer Screening
- Vaginal Cancer Screening
Products
- Instruments
- Consumables
- Services
Technology
- PCR
- Immunodiagnostics
- Others
End-users
- Hospitals & Clinics
- Laboratories
- Others
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Abbott Laboratories
- Qiagen N.V.
- Becton, Dickinson and Company
- Quest Diagnostics, Inc.
- Hologic, Inc.
- F. Hoffmann-La Roche AG
- Femasys, Inc.
- Arbor Vita Corporation
- NURX, Inc.
- Seegene, Inc.
- Thermo Fisher Scientific, Inc.
- BioMérieux SA
Key players competing in the HPV testing and Pap test market are Abbott Laboratories; Qiagen N.V.; Becton, Dickinson and Company; Quest Diagnostics, Inc.; Hologic, Inc.; F. Hoffmann-La Roche AG; Femasys, Inc.; Arbor Vita Corporation; NURX, Inc.; Seegene, Inc.; Thermo Fisher Scientific, Inc.; and bioMérieux SA. Qiagen N.V. developed the QIAscreen HPV PCR Test, in November 2018, which was a molecular diagnostic test used to diagnose HPV.
Our Clients
Related Reports
Some other reports from this category!
